Showcasing Its Pandemic Response Drug Discovery, Berkeley Lights Prepares For IPO
'Nanofludics' Accelerates Antibody Discovery
Established antibody discovery firms have accelerated their pace - but companies like Berkeley Lights promise it can move even faster 
